Evidence for paper review

Evidence and contribution. The study combines a 700-nm nanoporous SixNy membrane, integrated Au/Ti comb electrodes, low-amplitude ECIS, and neural-network classification. HUVEC impedance spectra were linked to microscopy and ZO-1/PECAM-1 staining across four operational phases: adherence, spreading, confluence, and mature barrier formation. Equivalent-circuit fitting reported Rtight increasing from 51 Ω in phase I to 446–510 Ω in phase IV, alongside increasing ZO-1 signal; this supports biological correspondence, but it is correlational rather than proof that Rtight uniquely measures tight-junction strength.Device and biological validation

Reported aggregate metrics; values are approximate as stated by the authors. The nanoporous-chip estimate derives from cross-system testing, not an independently trained model.Reported model performance

What is convincing—and what remains uncertain

• Convincing: the electrical signal changes systematically with maturation, and the model recognizes mature phases relatively well. KAN reportedly achieved comparable nanoporous-chip performance while using 30% of the glass-chip training data, suggesting a potentially efficient classifier, although model-size and training-time comparisons need fuller numerical reporting.Model behavior
• Important qualification: the principal validation is not fully independent in the strongest sense: the model learned labels derived from microscopy, the nanoporous test set contained only six chips, and training was mainly performed on a different glass-bottom platform. Chip-level rather than spectrum-level splitting is essential because repeated measurements from the same chip can otherwise inflate apparent generalization; the supplied text does not clearly establish that all splits were independent by chip.
• Biological scope: only HUVECs were evaluated. Therefore, “barrier” recognition is demonstrated for this endothelial model, not for epithelial, brain, intestinal, ocular, diseased, multicellular, or patient-derived barriers.Experimental scope
• Drug perturbation: PN159 was associated with reversible weakening and BAC with persistent disruption after washing, but the experiment lacked reported independent sample sizes and tested only two compounds at two concentrations. The neural-network phase label is an impedance-derived state assignment; it should not by itself be interpreted as molecular mechanism or direct permeability measurement.Perturbation experiment

Bottom-line assessment

This is a strong engineering and proof-of-concept study, not yet a validated general-purpose replacement for microscopy, TEER, permeability assays, or molecular characterization. Confidence is moderate for automated recognition of mature HUVEC states on closely related chips and low-to-moderate for broader biological generalization. The conclusion would materially change with preregistered chip-level splits, larger multi-batch validation, public raw impedance data and code, calibration/uncertainty estimates, blinded external testing, additional barrier models, and direct permeability comparison. The paper reports funding from TU Braunschweig, the Niedersächsische Landesregierung, and Volkswagen Stiftung, declares no conflicts, and states that supporting data are available on reasonable request; these factors should be considered when assessing transparency and reproducibility.Transparency and limitations

Further author reviews: